NexMed Receives over $2.7 Million Cash Infusion (Business Wire)

SAN DIEGO----NexMed, Inc. , a specialty CRO with a pipeline of products based on the NexACT® technology , announced today that it has raised $2.3 million in a private placement of promissory notes from two accredited U.S. investors.